Biomaterials Group

 The Biomaterials group is a multidisciplinary team dedicated to the development of bioactive materials and medical devices which can enhance the society wellbeing and health. Our main interest is focused on the design and synthesis of functional polymers with a defined therapeutic action for the development of new eluting systems for bioactive compounds such as drugs, cell-signaling factors and biomolecules, which can be applied as nanoparticles, hydrogels or bioactive coatings for medical devices.

Linked to this activity our group endears our activities with a dedicated effort to produce high impact scientific publications, technical papers, patents and know-how developments, leading competitive projects funded by National and European agencies as well as private agreements with Biotech companies in the fields of vascular area, ophthalmology, musculoskeletal tissue engineering and regenerative medicine.

The Biomaterials Group is member of CIBER’s Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) form 2006 and also member of the UE EXPERTISSUES Network of excelence and has been distinguished with the EXPERTISSUES QA CERTIFICATE